Analysts see 35% upside for Honeywell Aerospace (HONA) as Jim Cramer highlights undervaluation

On Tuesday, stocks rose as Wall Street aimed to finish a strong first half of the year, despite ongoing geopolitical concerns and questions about AI spending sustainability. West Texas Intermediate crude stabilized above $70 a barrel following a U.S.-Iran agreement to cease attacks in the Strait of Hormuz.

Investors are shifting focus within the AI sector, favoring semiconductor suppliers like Micron, which Jim Cramer highlighted for its clear multi-year demand visibility. He expressed confidence in Micron as a compelling investment in the AI buildout.

Cardinal Health, another Club holding, continued its rally after recovering from what Cramer deemed an unjustified sell-off, attributing its earlier weakness to sector rotation rather than fundamental issues. He praised CEO Jason Hollar's performance and noted that Cardinal Health and Eli Lilly are benefiting from renewed investor interest in healthcare.

Additionally, shares of Honeywell Aerospace rose nearly 2% as it operates independently after separating from Honeywell Technologies. Cramer believes the market undervalues Honeywell Aerospace and sees a potential 35% upside from current levels, emphasizing the strength of its aerospace business.

Overall, the commentary reflects a positive outlook on specific sectors and companies, suggesting potential investment opportunities for investors looking to capitalize on market trends

Stocks in this article

Company Price Change Change % AI
Honeywell HON.US 224.49 -3.31 -1.46% Buy
Cardinal Health CAH.US 238.97 +2.75 +1.16% Buy
Eli Lilly LLY.US 1,215.82 -14.11 -1.15% Buy
Micron MU.US 1,156.34 +11.06 +0.97% Buy

More business news